J Bladé

International uniform response criteria for multiple myeloma

Brian G.M. Durie, J-L Harousseau, Jesús F. San Miguel et al. · Leukemia · 2006 · 2.6K citations

Medicine, Hematology, Oncology +12

Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates.

José Vicente Bagán Sebastián, J Bladé, José Manuel Cózar et al. · PubMed · 2007 · 100 citations

Medicine, Oncology, Surgery +13

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression

MV Mateos, Miguel‐Teodoro Hernández, Norma C. Gutiérrez et al. · Haematologica · 2008 · 88 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.

Xavier Filella, J Bladé, Ángel Guillermo et al. · PubMed · 1996 · 56 citations

Medicine, Immunology, Oncology +16

Combination of interferon and dexamethasone in refractory multiple myeloma

Jesús F. San Miguel, Marı́a Jesús Moro, J Bladé et al. · Hematological Oncology · 1990 · 21 citations

Pharmacy, Pharmacology, Pharmacotherapy +17